fluoxetine has been researched along with Fatigue Syndrome, Chronic in 12 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Fatigue Syndrome, Chronic: A syndrome characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. (From Semin Neurol 1998;18(2):237-42; Ann Intern Med 1994 Dec 15;121(12): 953-9)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bupropion responders were more likely to have trough blood levels above 30 ng/ml (chi 2 = 3." | 1.28 | Bupropion treatment of fluoxetine-resistant chronic fatigue syndrome. ( Brickman, A; Goodnick, PJ; Klimas, NG; Sandoval, R, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (83.33) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pardini, M | 1 |
| Guida, S | 1 |
| Primavera, A | 1 |
| Krueger, F | 1 |
| Cocito, L | 1 |
| Gialloreti, LE | 1 |
| Singh, A | 1 |
| Garg, V | 1 |
| Gupta, S | 1 |
| Kulkarni, SK | 1 |
| Hickie, I | 1 |
| Wilson, A | 1 |
| Vercoulen, JH | 1 |
| Swanink, CM | 1 |
| Zitman, FG | 1 |
| Vreden, SG | 1 |
| Hoofs, MP | 1 |
| Fennis, JF | 1 |
| Galama, JM | 1 |
| van der Meer, JW | 1 |
| Bleijenberg, G | 1 |
| Cleare, AJ | 1 |
| Wessely, SC | 1 |
| Sharma, A | 1 |
| Kendall, MJ | 1 |
| Oyebode, F | 1 |
| Jones, D | 1 |
| Lynch, S | 2 |
| Seth, R | 1 |
| Wearden, AJ | 1 |
| Morriss, RK | 1 |
| Mullis, R | 1 |
| Strickland, PL | 1 |
| Pearson, DJ | 1 |
| Appleby, L | 1 |
| Campbell, IT | 1 |
| Morris, JA | 1 |
| Deale, A | 1 |
| Chalder, T | 1 |
| Wessely, S | 1 |
| Fraser, J | 1 |
| Everitt, BS | 1 |
| Goodnick, PJ | 1 |
| Sandoval, R | 1 |
| Brickman, A | 1 |
| Klimas, NG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Shanghai University of Traditional Chinese Medicine[NCT03496961] | 135 participants (Anticipated) | Interventional | 2018-12-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for fluoxetine and Fatigue Syndrome, Chronic
| Article | Year |
|---|---|
Amisulpride vs. fluoxetine treatment of chronic fatigue syndrome: a pilot study.
Topics: Amisulpride; Dopamine Antagonists; Fatigue Syndrome, Chronic; Female; Fluoxetine; Humans; Male; Pilo | 2011 |
Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome.
Topics: Adult; Antidepressive Agents, Second-Generation; Case-Control Studies; Depressive Disorder; Double-B | 1996 |
Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome.
Topics: Adult; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Double-Blind Method; Exe | 1998 |
9 other studies available for fluoxetine and Fatigue Syndrome, Chronic
| Article | Year |
|---|---|
Role of antioxidants in chronic fatigue syndrome in mice.
Topics: Animals; Antioxidants; Brain; Carbazoles; Carvedilol; Catalase; Disease Models, Animal; Fatigue Synd | 2002 |
A catecholamine model of fatigue.
Topics: Activities of Daily Living; Adolescent; Adult; Aged; Benzamides; Brain; Catecholamines; Depressive D | 1994 |
Fluoxetine and chronic fatigue syndrome.
Topics: Antidepressive Agents, Second-Generation; Fatigue Syndrome, Chronic; Fluoxetine; Humans; Somatoform | 1996 |
Fluoxetine and chronic fatigue syndrome.
Topics: Antidepressive Agents, Second-Generation; Fatigue Syndrome, Chronic; Fluoxetine; Humans | 1996 |
Fluoxetine and chronic fatigue syndrome.
Topics: Antidepressive Agents, Second-Generation; Fatigue Syndrome, Chronic; Fluoxetine; Humans; Placebo Eff | 1996 |
Commentary on: randomised, double-blind, placebo-controlled trial of fluoxetine and graded exercise for chronic fatigue syndrome.
Topics: Adult; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Exercise Therapy; Fatigu | 1998 |
Fluoxetine and graded exercise in chronic fatigue syndrome.
Topics: Antidepressive Agents, Second-Generation; Combined Modality Therapy; Exercise Therapy; Fatigue Syndr | 1998 |
Analysis of drop-out data in treatment trials.
Topics: Data Interpretation, Statistical; Exercise Therapy; Fatigue Syndrome, Chronic; Fluoxetine; Humans; P | 1998 |
Bupropion treatment of fluoxetine-resistant chronic fatigue syndrome.
Topics: Adult; Bupropion; Depressive Disorder; Fatigue Syndrome, Chronic; Female; Fluoxetine; Follow-Up Stud | 1992 |